Skip to main content
. 2022 Oct 19;13(11-12):1875–1890. doi: 10.1007/s13300-022-01324-x

Table 3.

Health state utilities and disutilities

Event/state Utility/disutility References
T2D, no complication 0.785 ± 0.11 [43]
Angina disutility, year of event –0.09 ± 0.01 [41]
Congestive heart failure disutility, year of event –0.108 ± 0.01 [41]
Myocardial infarction disutility, year of event –0.055 ± 0.01 [41]
Stroke disutility, year of event –0.164 ± 0.01 [41]
Peripheral vascular disease disutility, year of event –0.061 ± 0.01 [41]
Gross proteinuria disutility, year of event –0.048 ± 0.01 [41]
Hemodialysis disutility, year of event –0.164 ± 0.03 [41]
Peritoneal dialysis disutility, year of event –0.204 ± 0.03 [41]
Kidney transplant disutility, year of event –0.023 ± 0.12 [41]
Background diabetic retinopathy disutility, year of event –0.04 ± 0.02 [41]
Proliferative diabetic retinopathy disutility, year of event –0.07 ± 0.02 [41]
Cataract disutility, year of event –0.016 ± 0.02 [41]
Macular edema disutility, year of event –0.04 ± 0.02 [41]
Severe vision loss/blindness disutility, year of event –0.074 ± 0.01 [41]
Neuropathy disutility, year of event –0.084 ± 0.01 [41]
Active foot ulcer disutility, year of event –0.17 ± 0.01 [41]
Amputation disutility, year of event –0.28 ± 0.01 [41]
Diurnal severe hypoglycemia event (SHE1 and SHE2) requiring any third party medical assistance –0.047 ± 0.014 [42]
Nocturnal severe hypoglycemia event (SHE1 and SHE2) requiring any third party medical assistance –0.051 ± 0.014 [42]